CIK 0000320017
- Non-accelerated filer
- Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222343568
- Phone
- +1 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-09 | Buck Kristen K EVP, R&D and CMO | Shares withheld for taxes | −1,908 | $3.80 | $7K | 80,250 |
| 2025-01-09 | Buck Kristen K EVP, R&D and CMO | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2025-01-09 | Flowers Cynthia Louise Director | Grant or award | +15,789 | 64,990 | ||
| 2025-01-09 | BROWN GREGORY B Director | Grant or award | +15,789 | 65,203 | ||
| 2025-01-09 | Mazzo David J President & CEO | Grant or award | +81,000 | 295,152 | ||
| 2025-01-09 | Mazzo David J President & CEO | Shares withheld for taxes | −9,414 | $3.80 | $36K | 285,738 |
| 2025-01-09 | Mazzo David J President & CEO | Shares withheld for taxes | −10,925 | $3.80 | $42K | 274,813 |
| 2025-01-09 | Mazzo David J President & CEO | Shares withheld for taxes | −7,017 | $3.80 | $27K | 267,796 |
| 2025-01-09 | Mazzo David J President & CEO | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-01-09 | AZAB MOHAMMAD Director | Grant or award | +15,789 | 74,469 | ||
| 2025-01-09 | HENSON HEIDI Director | Grant or award | +15,789 | 55,269 | ||
| 2025-01-09 | KLOSK STEVEN M Director | Grant or award | +15,789 | 65,359 | ||
| 2024-10-01 | Nisco James SVP, Fin/Treas, Chief Actg Off | Grant or award | +3,300 | $2.93 | $10K | 14,657 |
| 2024-10-01 | Nisco James SVP, Fin/Treas, Chief Actg Off | Shares withheld for taxes | −1,701 | $2.93 | $5K | 12,956 |
| 2024-10-01 | Buck Kristen K EVP, R&D and CMO | Grant or award | +15,000 | $2.93 | $44K | 69,035 |
| 2024-10-01 | Buck Kristen K EVP, R&D and CMO | Shares withheld for taxes | −6,363 | $2.93 | $19K | 62,672 |
| 2024-10-01 | Mazzo David J President & CEO | Grant or award | +58,000 | $2.93 | $170K | 238,798 |
| 2024-10-01 | Mazzo David J President & CEO | Shares withheld for taxes | −26,964 | $2.93 | $79K | 211,834 |
| 2024-01-11 | Mazzo David J Chief Executive Officer | Shares withheld for taxes | −1,026 | $2.99 | $3K | 174,766 |
| 2024-01-10 | Buck Kristen K EVP, R&D and CMO | Shares withheld for taxes | −512 | $3.00 | $2K | 54,035 |
Page 3 of 18 · 345 trades